Matrix metalloproteinase inhibitor: Differential effects on pulmonary neutrophil and monocyte sequestration following cardiopulmonary bypass

Journal of Extra-Corporeal Technology

Volumn 31, Issue 2, 1999, Pages 67-75

  McCann II, Ulysse G ^a   Gatto, Louis A ^b   Searles, Bruce ^a   Carney, David E ^a   Lutz, Charles J ^a   Picone, Anthony L ^a   Schiller, Henry J ^a   Nieman, Gary F ^a,c  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Acute lung injury; Bypass; Metalloproteinase inhibitor; Monocyte; Neutrophil; Post perfusion syndrome

Indexed keywords

CHEMOKINE; ELASTASE; LIPOPOLYSACCHARIDE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; TETRACYCLINE DERIVATIVE;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DRUG EFFECT; HISTOMETRY; LEUKOCYTE ACTIVATION; LUNG INJURY; MONOCYTE; NEUTROPHIL; NONHUMAN;

EID: 0032722320     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993;55: 552-9.
2. Picone AL, Lutz CJ, Finck C, et al. Multiple sequential insults cause post-pump syndrome. Ann Thorac Surg. 1999;67:978-985.
3. Braude S, Apperley J, Krausz T, Goldman JM, Royston D. Adult respiratory distress syndrome after allogeneic bone marrow transplantation: evidence for a neutrophil independent mechanism. Lancet 1985;I:1239-1242.
4. Ognibene FP, Martin SE, Parker MM, et al. Adult respiratory distress syndrome in patients with severe neutropenia. N Engl J Med. 1986;315:547-551.
5. Maunder RJ, Hackman RC, Riff E, Albert RK, Springmeyer SC. Occurrence of the adult respiratory distress syndrome in neutropenic patients. Am Rev Respir Dis. 1986;133:313-316.
6. Rinaldo JE. Mediation of ARDS by leukocytes. Chest. 1986;89:590-593.
7. Johnson D, Thomson D, Hurst T, et al. Neutrophil-mediated acute lung injury after extracorporeal perfusion. J Thorac Cardiovasc Surg. 1994;107:1193-1202.
8. Tonz M, Mihaljevic T, Von Segesser LK, Fehr J, Schmid ER, Turina MI. Acute lung injury during cardiopulmonary bypass: are the neutrophils responsible? Chest. 1995;108: 1551-56.
9. Butler J, Pillai R, Rocker GM, Westaby S, Parker D, Shale DJ. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg.1993;105:25-30.
10. Faymonville ME, Pincemail J, Duchateau J, et al. Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans. J Thorac Cardiovasc Surg. 1991;102:309-17.
11. Torii K, Iida KI, Miyazaki Y, et al. Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am J Resp Crit Care Med. 1997;155:43-46.
12. Janoff A, Scherer J. Mediators of inflammation in leukocyte lysosomes, IX. Elastolytic activity in granules of human polymorphonuclear leukocytes. J Exp Med. 1968;128:1137-1155.
13. Gadek JE, Fells GA, Wright DG, Crystal RG. Human neutrophil elastase functions as a type III collagen "collagenase." Biochem Biophys Res Commun. 1980; 95:1815-1822.
14. Mainardi CL, Dixit SN, Kang AR. Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocytes granules. J Biol Chem. 1980;255:5435-5441
15. McDonald JM, Kelley DG, Degradation of fibronectin by leukocyte elastase: release of biologically active fragments. J Biol Chem. 1980;255:8848-8858.
16. Kawamura M, Yamasawa F, Ishizaka A, et al. Serum concentration of 7S collagen and prognosis in patients with the adult respiratory distress syndrome. Thorax. 1994;49: 144-146.
17. Suter PM, Suter S, Girardin E, Roux LP, Grau GE, Dayer JM. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis. 1992;145: 1016-1022.
18. Mallya SK, Hall JE, Lee H, Roemar EJ, Simon SR, Golub LM. Interaction of matrix metalloproteinases with serine protease inhibitors: new potential roles for matrix metalloproteinase inhibitors. Ann NY Acad Sci. 1994;732:303-314.
19. Carney DE, Lutz CJ, Picone AL, et al. Matrix metalloproteinase inhibitor prevents acute lung injury following cardiopulmonary bypass. Circulation. 1999;100:400-406.
20. Gunderson HJ. Estimators of the number of objects per area unbiased by edge effects. Microsc Acta. 1978;81(2): 107-117.
21. Ryan ME, Ramamurthy NS, Golub LM. Matrix metalloproteinases and their inhibition in periodontal treatment. Curr Opin Periodontol. 1994;3:85-96.
22. Okada Y, Nagese H, Harris ED Jr. A metalloproteinase form human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. J Biol Chem. 1986;261(30):14245-14255.
23. Rollins BJ. Chemokines. Blood. 1997;90(3):909-928.
24. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Eng J Med. 1998;339(7):436-45.
25. Smith RE, Hogaboam CM, Strieter RM, Lukacs NW, Kunkel SL. Cell-to-cell and cell-to-matrix interactions mediate chemokine expression: an important component of the inflammatory lesion. J Leukoc Biol. 1997;62:612-619.